Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03297606
Title Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Canadian Cancer Trials Group
Indications

Advanced Solid Tumor

non-Hodgkin lymphoma

multiple myeloma

Therapies

Bosutinib

Palbociclib

Vismodegib

Ipilimumab + Nivolumab

Cobimetinib + Vemurafenib

Temsirolimus

Olaparib

Erlotinib

Crizotinib

Sunitinib

Afatinib

Dasatinib

Pertuzumab + Trastuzumab

Axitinib

Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Cross Cancer Institute Recruiting Edmonton Alberta T6G 1Z2 Canada Details
BCCA - Cancer Centre for the Southern Interior Suspended Kelowna British Columbia V1Y 5L3 Canada Details
BCCA - Vancouver Cancer Centre Recruiting Vancouver British Columbia V5Z 4E6 Canada Details
Kingston Health Sciences Centre Recruiting Kingston Ontario K7L 2V7 Canada Details
London Regional Cancer Program Recruiting London Ontario N6A 5W9 Canada Details
Ottawa Hospital Research Institute Recruiting Ottawa Ontario K1H 8L6 Canada Details
University Health Network Recruiting Toronto Ontario M5G 2M9 Canada Details
The Jewish General Hospital Recruiting Montreal Quebec H3T 1E2 Canada Details
Allan Blair Cancer Centre Recruiting Regina Saskatchewan S4T 7T1 Canada Details
Saskatoon Cancer Centre Recruiting Saskatoon Saskatchewan S7N 4H4 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field